← Back to Clinical Trials
Recruiting NCT06446336

NCT06446336 Creation of a Pre-operative Score, the HASS Score, for Injuries Reliable Diagnosis of Long Biceps Tendon

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06446336
Status Recruiting
Phase
Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Condition Biceps Tendon Disorder
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2024-05-01
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
HASS Score

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2024-05-01 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The long biceps tendon (LBT) has a particular anatomical pathway, making it fragile due to repeated microtrauma or trauma which can lead to chronic lesions of LBT. Current issue with this pathology is the absence of preoperative effective clinical and paraclinical tools, allowing confirmed diagnosis, in particular because of its entanglement with other pathologies. This diagnostic uncertainty generates an approximation for LBT therapeutic indications so that therapeutic indications are frequently finalized during glenohumeral arthroscopy. Having a reliable and reproducible diagnostic tool for LBT pathologies would allow an improvement in their surgical load management . In this context, this research is based on the hypothesis that the construction of a pre-operative score, the HASS score, combining pre-operative clinical and paraclinical data would allow to obtain a reliable diagnosis of LBT injuries.

Eligibility Criteria

Inclusion Criteria: * Patient with operative indication for tenodesis tenotomy, represented by persistence of clinical signs after medical treatment for more than 6 months * Patient with shoulder pain lasting more than 6 months Exclusion Criteria: * Patient with a ruptured LBT on the pre-operative imaging assessment

Contact & Investigator

Central Contact

Olivier COURAGE, MD

✉ o.courage@wanadoo.fr

📞 + 33 2 76 89 97 93

Frequently Asked Questions

Who can join the NCT06446336 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Biceps Tendon Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06446336 currently recruiting?

Yes, NCT06446336 is actively recruiting participants. Contact the research team at o.courage@wanadoo.fr for enrollment information.

Where is the NCT06446336 trial being conducted?

This trial is being conducted at Le Havre, France.

Who is sponsoring the NCT06446336 clinical trial?

NCT06446336 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology